Monitoring early tumor response to drug therapy with diffuse optical tomography
Journal Article
Overview
publication date
has subject area
-
Angiogenesis Modulating Agents - Angiogenesis Inhibitors
-
Animals
-
Antineoplastic Agents - Angiogenesis Inhibitors
-
Blood Proteins - Antibodies, Monoclonal, Humanized
-
Blood Proteins - Bevacizumab
-
Blood Proteins - Hemoglobins
-
Blood Proteins - Oxyhemoglobins
-
Coloring Agents - Fluorescent Dyes
-
Diagnostic Imaging - Perfusion Imaging
-
Diagnostic Imaging - Tomography, Optical
-
Diagnostic Techniques, Radioisotope - Perfusion Imaging
-
Drug Monitoring
-
Environment and Public Health - Analysis of Variance
-
Female
-
Globins - Hemoglobins
-
Globins - Oxyhemoglobins
-
Globulins - Antibodies, Monoclonal, Humanized
-
Globulins - Bevacizumab
-
Growth Inhibitors - Angiogenesis Inhibitors
-
Health Care Evaluation Mechanisms - Analysis of Variance
-
Immunoproteins - Antibodies, Monoclonal, Humanized
-
Immunoproteins - Bevacizumab
-
Investigative Techniques - Analysis of Variance
-
Investigative Techniques - Tomography, Optical
-
Investigative Techniques - Xenograft Model Antitumor Assays
-
Lectins - Plant Lectins
-
Luminescent Agents - Fluorescent Dyes
-
Magnetic Resonance Imaging
-
Mice
-
Mice, Nude
-
Models, Animal - Neoplasms, Experimental
-
Neoplasm Transplantation - Xenograft Model Antitumor Assays
-
Neoplasms - Neoplasms, Experimental
-
Neovascularization, Pathologic
-
Plant Proteins - Plant Lectins
-
Tomography - Tomography, Optical
has restriction
Date in CU Experts
-
December 10, 2013 9:16 AM
Full Author List
-
Flexman ML; Vlachos F; Kim HK; Sirsi SR; Huang J; Hernandez SL; Johung TB; Gander JW; Reichstein AR; Lampl BS
author count
citation count
published in
Other Profiles
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)
Additional Document Info
volume
issue
number